A series of studies focused on seeking predictive markers of screening MS among the PCOS population, such as lipid accumulation product (LAP), visceral adiposity index (VAI), triglyceride-glucose index (TyG), TG/HDL-C ratio, ApoB/ApoA1 ratio, and so on (8, 14, 39, 40). The gene discussed is APOA1; the disease is myeloid sarcoma.